ID   BOT-2
AC   CVCL_T293
SY   Breast Original Tumor-2
DR   Wikidata; Q54797955
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=171063;
RX   PubMed=212193;
CC   Population: Caucasian.
CC   Doubling time: 16-18 hours (PubMed=171063).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz A.;
RT   "Cell lines from human breast.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994).
//
RX   PubMed=171063;
RA   Nordquist R.E., Ishmael D.R., Lovig C.A., Hyder D.M., Hoge A.F.;
RT   "The tissue culture and morphology of human breast tumor cell line
RT   BOT-2.";
RL   Cancer Res. 35:3100-3105(1975).
//
RX   PubMed=212193;
RA   Engel L.W., Young N.A.;
RT   "Human breast carcinoma cells in continuous culture: a review.";
RL   Cancer Res. 38:4327-4339(1978).
//